Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

SMILE: Klinisk forsøg for at evaluere mindfulness som intervention for racemæssige og etniske befolkninger under COVID-19 (SMILE)

Digital Health Platform (DHP) til at levere Mindfulness som en stresshåndteringsintervention ved at udnytte elektroniske (SMILE) sundhedsjournaler for racemæssige og etniske befolkninger under COVID-19-pandemien: klinisk forsøg

Målet med dette kliniske forsøg er at evaluere SMILE-appen, en Digital Health Platform (DHP), der vil levere en mindfulness-intervention, designet til at afbøde COVID-relateret stress. Derudover vil SMILE-appen eksternt indsamle selvrapporterede psykologiske og fysiologiske målinger for mental sundhed og autonom regulering. Undersøgelsesdeltagere er voksne, der selv identificerer sig som afroamerikanere, sorte og/eller latinoer, og som har klinisk signifikante niveauer af angst.

Studiets mål er:

  • Mål 1: Etablere effektiviteten og holdbarheden af ​​en 8-ugers Mindfulness DHP-intervention. Efterforskerne vil fokusere på to konstruktioner, der er vigtige for mental sundhed og antage, at: A) Angst, selvrapportering af stress og livskvalitetsmålinger vil forbedres væsentligt ved sammenligning: A.1) Pre-to-post intervention, og; A.2) Kontrol vs. interventionsgrupper over 8 uger og ved 1-måneders opfølgning. B) Arousal, autonome indekser for HRV (som afspejler parasympatisk aktivering) vil forbedres væsentligt, når man sammenligner: B.1) Pre-to-post intervention, og; B.2) Kontrol vs. interventionsgrupper over 8 uger og ved 1-måneders opfølgning.
  • Mål 2: Etablere bæredygtigheden af ​​to Mindfulness DHP-interventioner ved at bruge fastholdelse, brug (frekvens) og deltagertilfredshed.
  • Mål 3: Undersøg sammenhænge mellem COVID-19-relateret stress, mentale sundhedsresultater og HRV. Undersøg, i hvilket omfang COVID-19-relaterede stress- og mentale helbredssymptomer er forbundet med HRV ved baseline, og hvordan dette forhold ændrer sig over tid.

Deltagerne vil blive tildelt 1 af 3 arme af undersøgelsen: MTIA-intervention, MAPP-intervention eller ventelistekontrol. Alle deltagere får tilsendt en enhed med SMILE-appen installeret og udstyret til optagelse af hjertedata i hjemmet. Alle deltagere vil gennemføre de grundlæggende psykometriske målinger og den fysiologiske stresstest ved at bruge instruktionerne i SMILE-appen. De, der er tildelt MTIA- eller MAPP-interventionsgrupperne, vil derefter deltage i deres tildelte intervention i løbet af de efterfølgende 8 uger. I løbet af disse 8 uger vil psykometriske og fysiologiske data blive udfyldt hver anden uge for alle deltagere. 3 måneder efter den indledende baseline vil alle deltagere gennemføre en endelig psykometrisk/fysiologisk evaluering.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Al dataindsamling vil ske eksternt, og interventionssessioner vil være virtuelle (dvs. i deltagernes hjem). Deltagerne vil blive forsynet med en tablet fyldt med SMILE-appen og en pulsmåler og vil se eller deltage i en virtuel introduktionsvejledning om brugen af ​​udstyret. Alle psykologiske og fysiologiske data vil blive indsamlet via SMILE-appen. Deltagerne vil blive tildelt 1 ud af 3 grupper (MTIA, MAPP, WLC), og alle deltagere vil gennemføre hver planlagt vurdering, uanset gruppeopgaven.

  1. Baseline vurdering (uge 0). Deltagerne vil udfylde demografiske og psykologiske spørgeskemaer efterfulgt af en HRV-vurderingsprotokol, som består i at bede deltagerne om at vedhæfte pulsmåleren og følge instruktionerne/modellen på appen for at gennemføre en kognitiv stresstest og en ortostatisk test.

    Ud over det demografiske spørgeskema er de psykologiske mål, der indgår i baseline-vurderingen: GAD-7, COVID Stress Scale (COVID-SS), Connor-Davidson Resilience Scale (CD RISC), Mental Health Quality of Life (MHQoL), Coping Orientering til Opgørelse over Oplevede Problemer (Kort COPE), Perceived Stress Scale (PSS), Posttraumatic Growth Inventory (PTGI), søvnforstyrrelse (Voksen Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form), PTSD Checkliste, Center for Epidemiologiske Studier Depression Skala (CES-D), Cognitive and Affective Mindfulness Scale-Revised (CAMS-R) og fysisk sundhed (Short Form Health Survey, SF-12).

  2. Intervention (uge 1-8). Deltagere, der er tilknyttet MTIA- og MAPP-grupperne, vil deltage i 8 ugers intervention. Begge interventionsprogrammer er mindful meditative praksisser, designet til at dyrke regulering af opmærksomheden til nutidens bevidsthed, samt udvikle mindfulness og bevidsthedsfærdigheder for at forbedre mestring og reducere stress og derved sænke angst og øge velvære.

    MTIA vil være instruktørledet, internet-leveret (via Zoom), interaktiv, gruppebaseret mindfulness-træningsintervention, der vil inkorporere træningen for cirka 9 personer i et gruppeformat med opgaver uden for sessionen. MindfulnessAPP (MAPP) er en selvadministreret, internet-leveret intervention udviklet af SMILE-undersøgelsesteamet.

    Hver anden uge i uge 1-6 vil deltagere i alle grupper blive bedt om at udfylde vurderinger, som inkluderer psykologiske spørgeskemaer (GAD-7, COVID-SS, CD RISC, CAMS-R) og den samme HRV-vurderingsprotokol som baseline. Deltagerne i begge mindfulnessgrupper vil blive bedt om at fremlægge dokumentation for mindfulness praksis.

  3. 8 ugers og opfølgende vurdering i uge 12: deltagere i alle grupper vil blive bedt om at udfylde vurderinger, som inkluderer psykologiske spørgeskemaer (GAD-7, COVID-SS, CD RISC, MHQoL, COPE, PSS, PTGI, PROMIS, PTSD-tjekliste, CES-D, CAMS-R og SF-12) og den samme HRV-vurderingsprotokol som baseline.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

398

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • North Carolina
      • Chapel Hill, North Carolina, Forenede Stater, 27599-7160
        • University of North Carolina At Chapel Hill

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inklusionskriterier:

  • selvidentificere som afroamerikaner, sort, latinamerikansk og/eller latino
  • demonstrere symptomer på angst, som bestemt baseret på GAD-7-screeningsmålet (score mellem 8-14)

Ekskluderingskriterier:

  • Aktuel eller historie med hjertesygdom
  • Anamnese med slagtilfælde eller demens
  • Diagnose af bevægelsesforstyrrelser, såsom Parkinsons sygdom eller lammelse
  • Diagnose af genetiske lidelser, såsom Downs syndrom eller Fragile-X syndrom
  • Diagnose af autisme
  • Diagnose af skizofreni, psykose, dissociativ lidelse, mani/bipolar lidelse, svær depression eller en personlighedsforstyrrelse
  • Anamnese med alvorlige psykiske eller adfærdsmæssige helbredsproblemer, der kræver et hospitals- eller behandlingscenterophold inden for de seneste 12 måneder
  • Tager hjertemedicin (bortset fra blodtryksmedicin)
  • Tager anfaldsmedicin
  • Tager i øjeblikket opioider medicin eller kosttilskud
  • Øvelse af formel mindfulness i mere end 15 minutter/dag i 4 eller flere dage/uge over de seneste 6 måneder
  • GAD-score <8 eller >14

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: "MTIA" indgreb
Den mindfulness træningsinstruktør administrerede ("MTIA") intervention vil inkorporere følgende elementer: træning i et 8-ugers, 90 minutter om ugen, modificeret mindfulness-program, som lægger yderligere vægt på træning, som er gennemførlig og relevant for race/etniske grupper , herunder: a) didaktik om relevans for stress, mestring og robusthed, b) opmærksom medfølelse for sig selv og andre; c) opmærksom kommunikation, herunder non-verbal opmærksomhed, opmærksom lytning og opmærksom tale. MTIA vil være instruktørledet, internet-leveret (via Zoom), interaktiv, gruppebaseret mindfulness-træningsintervention, der vil inkorporere træningen for cirka 9 personer i et gruppeformat med opgaver uden for sessionen.
Mindfulness-meditation er blevet beskrevet som en adfærdsteknik, der involverer bevidst selvregulering af opmærksomhed på nuet-øjebliksoplevelse, kombineret med frigivelse af kognitiv fiksering på tanker (hvad enten det er simple billeder eller komplekse historielinjer) om fortid eller fremtid. Gennem træning i mindfulness lærer individer at fremkalde og opretholde en ikke-dømmende tilstand af bevidsthed om nuet.
Aktiv komparator: "MAPP" indgreb
MindfulnessAPP ("MAPP") er en selvadministreret intervention udviklet af SMILE-undersøgelsesteamet. MAPP'en er til individuel brug, med otte MAPP-sessioner sammensat af mindfulness-øvelser og didaktik, der svarer til MTIA-sessionerne. Da den ugentlige MTIA-time vil vare 90 minutter, vil MAPP-opgaverne anbefale, at du bruger cirka 90 minutter om ugen på at dække den tildelte lektion, men i et fleksibelt format, der er praktisk for deltageren. Derudover vil hver session indeholde mindfulness-baserede øvelsesopgaver generelt fra 10 til 30 minutter om dagen. Det samlede antal foreslåede dage til afslutning vil være 49 dage, sammenlignelig med tiden fra start til slut af en traditionel 8 ugers MTIA-session; dog vil der være fleksibilitet inden for dette individualiserede program.
Mindfulness-meditation er blevet beskrevet som en adfærdsteknik, der involverer bevidst selvregulering af opmærksomhed på nuet-øjebliksoplevelse, kombineret med frigivelse af kognitiv fiksering på tanker (hvad enten det er simple billeder eller komplekse historielinjer) om fortid eller fremtid. Gennem træning i mindfulness lærer individer at fremkalde og opretholde en ikke-dømmende tilstand af bevidsthed om nuet.
Ingen indgriben: Ventelistekontrol
Ventelistekontrolgruppen (WLC) deltager i alle forskningsvurderingssessioner, men vil ikke blive tilbudt Mindfulness-interventionen, før deres rolle i forskningen er afsluttet.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change From Baseline to Post-Intervention in the Generalized Anxiety Disorder-7 Scale
Tidsramme: Baseline, 8 week
Generalized Anxiety Disorder scale (GAD-7) is a 7-item self-report questionnaire measuring the frequency of anxiety over the prior 2 weeks. Response categories range from 0 ("Not at all") to 3 ("Nearly every day"). Scores are summed leading to a range of 0-21. Higher scores indicate greater anxiety symptoms. The among-group differences in the change scores are compared by ANOVA.
Baseline, 8 week
Change From Baseline to Follow-up in the Generalized Anxiety Disorder-7 Scale
Tidsramme: Baseline, 12 weeks
Generalized Anxiety Disorder scale (GAD-7) is a 7-item self-report questionnaire measuring the frequency of anxiety over the prior 2 weeks. Response categories range from 0 ("Not at all") to 3 ("Nearly every day"). Scores are summed leading to a range of 0-21. Higher scores indicate greater anxiety symptoms. The among-group differences in the change scores are compared by ANOVA.
Baseline, 12 weeks

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Ændring i Short Form Health Survey (SF-12), baseline til opfølgning
Tidsramme: Baseline, 12 uger
Short Form Health Survey (SF-12) er et 12-elements selvrapporteringsspørgeskema, der vurderer aspekter af fysisk sundhed og mentalt velvære. Scoring er kompleks og omfatter både positive og negativt formulerede elementer og oversættes til en score på 0-100. Højere score indikerer bedre fysisk og mental sundhed.
Baseline, 12 uger
Ændring i COVID-19 Stress Scale Baseline til post-intervention
Tidsramme: Baseline, 8 uger
COVID-19 Stress Scale (forkortet) er et selvrapporterende spørgeskema med 18 punkter designet til at måle COVID-relateret angst over de seneste 7 dage. Tre højt korrelerede underskalaer måles: Fare, Forurening og Traumatisk stress. Underskalaerne Fare og forurening spørger om bekymringer relateret til virussen med svarkategorier, der spænder fra 0 ("Slet ikke") til 4 ("Ekstremt). Traumatisk stress-underskalaen spørger om hyppighed af symptomer og varierer fra 0 ("Aldrig") til 4 ("Næsten altid"). Svar summeres på tværs af underskalaerne for et interval på 0-72 med højere værdier, der indikerer større COVID-relateret stress. To af underskalaerne, Compulsive Checking og Xenofobi relateret til COVID, er ikke længere relevante og er ikke inkluderet.
Baseline, 8 uger
Ændring i COVID-19 Stress Scale Baseline til opfølgning
Tidsramme: Baseline, 12 uger
COVID-19 Stress Scale (forkortet) er et selvrapporterende spørgeskema med 18 punkter designet til at måle COVID-relateret angst over de seneste 7 dage. Tre højt korrelerede underskalaer måles: Fare, Forurening og Traumatisk stress. Underskalaerne Fare og forurening spørger om bekymringer relateret til virussen med svarkategorier, der spænder fra 0 ("Slet ikke") til 4 ("Ekstremt). Traumatisk stress-underskalaen spørger om hyppighed af symptomer og varierer fra 0 ("Aldrig") til 4 ("Næsten altid"). Svar summeres på tværs af underskalaerne for et interval på 0-72 med højere værdier, der indikerer større COVID-relateret stress. To af underskalaerne, Compulsive Checking og Xenofobi relateret til COVID, er ikke længere relevante og er ikke inkluderet.
Baseline, 12 uger
Change in Autonomic Activity From Baseline to Post-Intervention as Measured by Heart Period
Tidsramme: Baseline, 8 weeks
Heart period (time in milliseconds between heartbeats) will be measured using the Polar H10 device. Range: 200-1500 msec
Baseline, 8 weeks
Change in Autonomic Activity From Baseline to Follow-up as Measured by Heart Period
Tidsramme: Baseline, 12 weeks
Heart period (time in milliseconds between heartbeats) will be measured using the Polar H10 device. Range: 200-1500 msec
Baseline, 12 weeks
Change in Parasympathetic Activity Baseline to Post-Intervention as Measured by High-frequency Heart Rate Variability (HF-HRV)
Tidsramme: Baseline, 8 weeks
High-frequency heart rate variability will be calculated from heart period data using CardioBatch Plus software. Range: 0 - 15 ln (msec)^2. Greater variability indicates greater parasympathetic activity.
Baseline, 8 weeks
Change in Parasympathetic Activity Baseline to Follow-up as Measured by High-frequency Heart Rate Variability (HF-HRV)
Tidsramme: Baseline, 12 weeks
High-frequency heart rate variability will be calculated from heart period data using CardioBatch Plus software. Range: 0 - 15 ln(msec)^2. Greater variability indicates greater parasympathetic activity.
Baseline, 12 weeks
Change in Vagal Efficiency Baseline to Post-intervention Measured Using HF-HRV and Heart Period Coupling
Tidsramme: Baseline, 8 weeks
Vagal Efficiency (VE) is calculated as the regression slope of heart period (HP, measured in milliseconds) on respiratory sinus arrhythmia (RSA, expressed as ln(ms²)) across short-time (15-second) epochs collected during seated, standing, and recovery periods of the sit-stand-sit task. VE is reported in units of ms / ln(ms²). The measure is computed only when each condition contains usable data and at least 6 valid epochs (≥50% of the condition).
Baseline, 8 weeks
Change in Vagal Efficiency Baseline to Follow-up Measured Using HF-HRV and Heart Period Coupling
Tidsramme: Baseline, 12 weeks
Vagal Efficiency (VE) is calculated as the regression slope of heart period (HP, measured in milliseconds) on respiratory sinus arrhythmia (RSA, expressed as ln(ms²)) across short-time (15-second) epochs collected during seated, standing, and recovery periods of the sit-stand-sit task. VE is reported in units of ms / ln(ms²). The measure is computed only when each condition contains usable data and at least 6 valid epochs (≥50% of the condition).
Baseline, 12 weeks
Change in the Cognitive and Affective Mindfulness Scale - Revised Baseline to Post-intervention.
Tidsramme: Baseline, 8 weeks.
The Cognitive and Affective Mindfulness Scale - Revised (CAMS-R) is a 12-item self report questionnaire that measures mindfulness in a single construct. Respondents are asked to rate how much each of the statements applies to them on a 1-4 scale with 1=Rarely/Not at all and 4 = Almost always resulting in total scores of 12-48. Higher scores reflect greater mindfulness. The among-group differences in the change scores are compared by ANOVA.
Baseline, 8 weeks.
Change in the Cognitive and Affective Mindfulness Scale - Revised Baseline to Follow-up
Tidsramme: Baseline,12 weeks.
The Cognitive and Affective Mindfulness Scale - Revised (CAMS-R) is a 12-item self report questionnaire that measures mindfulness in a single construct. Respondents are asked to rate how much each of the statements applies to them on a 1-4 scale with 1=Rarely/Not at all and 4 = Almost always resulting in total scores of 12-48. Higher scores reflect greater mindfulness. The among-group differences in the change scores are compared by ANOVA.
Baseline,12 weeks.
Change in the Perceived Stress Scale Baseline to Post-intervention.
Tidsramme: Baseline, 8 weeks
The Perceived Stress Scale (PSS) is a 10-item self-report questionnaire that measures the frequency of stress-related feelings in the past month. Responses vary from 0 ("Not at all" to 4 "Very often). Responses are summed resulting in a range of 0-40. Higher scores indicate higher perceived stress. The among-group differences in the change scores are compared by ANOVA.
Baseline, 8 weeks
Change in the Perceived Stress Scale Baseline to Follow-up.
Tidsramme: Baseline,12 weeks
The Perceived Stress Scale (PSS) is a 10-item self-report questionnaire that measures the frequency of stress-related feelings in the past month. Responses vary from 0 ("Not at all" to 4 "Very often). Responses are summed resulting in a range of 0-40. Higher scores indicate higher perceived stress. The among-group differences in the change scores are compared by ANOVA.
Baseline,12 weeks
Change in the Post-traumatic Growth Inventory Baseline to Post-Intervention
Tidsramme: Baseline, 8 weeks
The Posttraumatic Growth Inventory (PTGI) is a 21-item self-report measure of growth and self-improvement after a crisis. The measure consists of statements, such as "I changed my priorities about what is important in life." Responses vary from 0 ("I did not experience this change as a result of my crisis") to 5 ("I experienced this change to a very great degree as a result of my crisis," resulting in total scores of 0-105. Higher scores indicate more growth. The among-group differences in the change scores are compared by ANOVA.
Baseline, 8 weeks
Change in the Post-traumatic Growth Inventory Baseline to Follow-up
Tidsramme: Baseline, 12 weeks
The Posttraumatic Growth Inventory (PTGI) is a 21-item self-report measure of growth and self-improvement after a crisis. The measure consists of statements, such as "I changed my priorities about what is important in life." Responses vary from 0 ("I did not experience this change as a result of my crisis") to 5 ("I experienced this change to a very great degree as a result of my crisis," resulting in total scores of 0-105. Higher scores indicate more growth. The among-group differences in the change scores are compared by ANOVA.
Baseline, 12 weeks
Change in the Post-traumatic Stress Disorder Checklist for DSM-V, Baseline to Post-intervention.
Tidsramme: Baseline, 8 weeks
The PTSD Checklist (PCL-5) is a 20-item self-report questionnaire that measures key symptoms of PTSD in response to a traumatic event. Respondents indicate the degree to which they are bothered by each symptom with categories ranging from 0 ("Not at All") to 4 ("Extremely") resulting in total scores of 0-80. Higher scores indicate presence of more symptomatology. The among-group differences in the change scores are compared by ANOVA.
Baseline, 8 weeks
Change in the Post-traumatic Stress Disorder Checklist for DSM-V, Baseline to Follow-up.
Tidsramme: Baseline, 12 weeks
The PTSD Checklist (PCL-5) is a 20-item self-report questionnaire that measures key symptoms of PTSD in response to a traumatic event. Respondents indicate the degree to which they are bothered by each symptom with categories ranging from 0 ("Not at All") to 4 ("Extremely") resulting in total scores of 0-80. Higher scores indicate presence of more symptomatology. The among-group differences in the change scores are compared by ANOVA.
Baseline, 12 weeks
Change in the Center for Epidemiologic Studies Depression Scale From Baseline to Post-Intervention.
Tidsramme: Baseline, 8 weeks.
The Center for Epidemiologic Studies Depression Scale (CES-D) is a 20-item self-report questionnaire for assessing symptoms associated with depression. Response options range from 0 ("Rarely or None of the Time") to 3 ("Most or Almost All the Time"). Scores range from 0 to 60, with higher scores indicating greater depressive symptoms. The among-group differences in the change scores are compared by ANOVA.
Baseline, 8 weeks.
Change in the Center for Epidemiologic Studies Depression Scale From Baseline to Follow-up.
Tidsramme: Baseline, 12 weeks.
The Center for Epidemiologic Studies Depression Scale (CES-D) is a 20-item self-report questionnaire for assessing symptoms associated with depression. Response options range from 0 ("Rarely or None of the Time") to 3 ("Most or Almost All the Time"). Scores range from 0 to 60, with higher scores indicating greater depressive symptoms. The among-group differences in the change scores are compared by ANOVA.
Baseline, 12 weeks.
Change in the Connor-Davidson Resilience Scale From Baseline to Post-Intervention
Tidsramme: Baseline, 8 weeks
The Connor-Davidson Resilience Scale (CD RISC) is a 25-item self-report measure of resilience when faced with difficulties. Respondents are presented with a series of statements and asked how much the statements apply to them. Responses range from 0 ("Not at all true") to 4 ("True nearly all the time"). Responses are summed to range from 0 to 100. Higher scores indicate more resilience. The among-group differences in the change scores are compared by ANOVA.
Baseline, 8 weeks
Change in the Connor-Davidson Resilience Scale From Baseline to Post-Intervention
Tidsramme: Baseline, 12 weeks
The Connor-Davidson Resilience Scale (CD RISC) is a 25-item self-report measure of resilience when faced with difficulties. Respondents are presented with a series of statements and asked how much the statements apply to them. Responses range from 0 ("Not at all true") to 4 ("True nearly all the time"). Responses are summed to range from 0 to 100. Higher scores indicate more resilience. The among-group differences in the change scores are compared by ANOVA.
Baseline, 12 weeks
Change in the Mental Health Quality of Life Baseline to Post-Intervention
Tidsramme: Baseline, 8 weeks

Mental Health Quality of Life Total Score: Mental Health Quality of Life (MHQoL) is an 8-item self-report questionnaire. The Mental Health Quality of Life Total Score is calculated as a sum of the first 7 items (self-image, independence, mood, relationships, daily activities, physical health, and future), with response levels ranging from 0 ("Very dissatisfied") to 3 ("Very satisfied"). The total score has a range of 0-21. Higher scores indicate better quality of life.

The among-group difference in the change scores for both are compared by ANOVA.

Baseline, 8 weeks
Change in the Mental Health Quality of Life Baseline to Follow-up
Tidsramme: Baseline, 12 weeks

Mental Health Quality of Life Total Score: Mental Health Quality of Life (MHQoL) is an 8-item self-report questionnaire. The Mental Health Quality of Life Total Score is calculated as a sum of the first 7 items (self-image, independence, mood, relationships, daily activities, physical health, and future), with response levels ranging from 0 ("Very dissatisfied") to 3 ("Very satisfied"). The total score has a range of 0-21. Higher scores indicate better quality of life.

The among-group difference in the change scores for both are compared by ANOVA.

Baseline, 12 weeks
Change in the Problem-focused Coping Subscale of the Coping Orientation to Problems Experienced Inventory From Baseline to Post-intervention
Tidsramme: Baseline, 8 weeks
The Problem-focused coping subscale of the Coping Orientation to Problems Experienced Inventory is an 8-item, self-report subscale. Problem-focused coping refers to using informational support, planning, and positive reframing. Respondents rate the degree to which they have been using a coping style based on a series of statements with responses of 1 ("I haven't been doing this at all") to 4 ("I've been doing this a lot". Scores are averaged across items and range from 1-4. Higher scores indicate greater problem-focused coping.
Baseline, 8 weeks
Change in the Emotion-focused Coping Subscale of the Coping Orientation to Problems Experienced Inventory From Baseline to Post-intervention
Tidsramme: Baseline, 8 weeks
The Emotion-focused coping subscale of the Coping Orientation to Problems Experienced Inventory in a 12-item, self-report subscale. Emotion-focused coping refers to using venting, emotional support, humor, acceptance, self-blame, and religion. Respondents rate the degree to which they have been using a coping style based on a series of statements with responses of 1 ("I haven't been doing this at all") to 4 ("I've been doing this a lot". Scores are averaged across items and range from 1-4. Higher scores indicate greater emotion-focused coping.
Baseline, 8 weeks
Change in the Avoidant Coping Subscale of the Coping Orientation to Problems Experienced Inventory From Baseline to Post-intervention
Tidsramme: Baseline, 8 weeks
The avoidant-focused coping subscale of the Coping Orientation to Problems Experienced Inventory is an 8-item, self-report subscale. Avoidant coping refers to using self-distraction, denial, substance use, and behavioral disengagement. Respondents rate the degree to which they have been using a coping style based on a series of statements with responses of 1 ("I haven't been doing this at all") to 4 ("I've been doing this a lot". Scores are averaged across items and range from 1-4. Higher scores indicate greater avoidant coping.
Baseline, 8 weeks
Change in the Problem-focused Coping Subscale of the Coping Orientation to Problems Experienced Inventory From Baseline to Follow-up
Tidsramme: Baseline, 12 weeks
The Problem-focused coping subscale of the Coping Orientation to Problems Experienced Inventory is an 8-item, self-report subscale. Problem-focused coping refers to using informational support, planning, and positive reframing. Respondents rate the degree to which they have been using a coping style based on a series of statements with responses of 1 ("I haven't been doing this at all") to 4 ("I've been doing this a lot". Scores are averaged across items and range from 1-4. Higher scores indicate greater problem-focused coping.
Baseline, 12 weeks
Change in the Emotion-focused Coping Subscale of the Coping Orientation to Problems Experienced Inventory From Baseline to Follow-up
Tidsramme: Baseline, 12 weeks
The Emotion-focused coping subscale of the Coping Orientation to Problems Experienced Inventory in a 12-item, self-report subscale. Emotion-focused coping refers to using venting, emotional support, humor, acceptance, self-blame, and religion. Respondents rate the degree to which they have been using a coping style based on a series of statements with responses of 1 ("I haven't been doing this at all") to 4 ("I've been doing this a lot". Scores are averaged across items and range from 1-4. Higher scores indicate greater emotion-focused coping.
Baseline, 12 weeks
Change in the Avoidant Coping Subscale of the Coping Orientation to Problems Experienced Inventory From Baseline to Follow-up
Tidsramme: Baseline, 12 weeks
The avoidant-focused coping subscale of the Coping Orientation to Problems Experienced Inventory is an 8-item, self-report subscale. Avoidant coping refers to using self-distraction, denial, substance use, and behavioral disengagement. Respondents rate the degree to which they have been using a coping style based on a series of statements with responses of 1 ("I haven't been doing this at all") to 4 ("I've been doing this a lot". Scores are averaged across items and range from 1-4. Higher scores indicate greater avoidant coping.
Baseline, 12 weeks
Change in the Patient-Reported Outcomes Measurement Information System Sleep Disturbance 8b Short Form T-score, Baseline to Post-intervention.
Tidsramme: Baseline, 8 weeks

The Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance 8b Short Form assesses self-reported perceptions of sleep quality, sleep depth, and restoration over the past 7 days. This instrument includes 8 items rated on a 5-point Likert scale (1 = not at all to 5 = very much). Raw scores are summed and converted to standardized T-scores based on the PROMIS adult reference population. T-scores have a mean of 50 and a standard deviation of 10, where 50 represents the average level of sleep disturbance in the general U.S. population.

Higher T-scores indicate greater sleep disturbance (worse outcome), while lower T-scores indicate less sleep disturbance (better outcome). Clinically, T-scores of approximately 60 or higher are considered indicative of elevated sleep disturbance, and scores of 70 or higher may reflect severe sleep disturbance.

Baseline, 8 weeks
Change in the Patient-Reported Outcomes Measurement Information System Sleep Disturbance 8b Short Form T-score, Baseline to Follow-up.
Tidsramme: Baseline, 12 weeks

The Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance 8b Short Form assesses self-reported perceptions of sleep quality, sleep depth, and restoration over the past 7 days. This instrument includes 8 items rated on a 5-point Likert scale (1 = not at all to 5 = very much). Raw scores are summed and converted to standardized T-scores based on the PROMIS adult reference population. T-scores have a mean of 50 and a standard deviation of 10, where 50 represents the average level of sleep disturbance in the general U.S. population.

Higher T-scores indicate greater sleep disturbance (worse outcome), while lower T-scores indicate less sleep disturbance (better outcome). Clinically, T-scores of approximately 60 or higher are considered indicative of elevated sleep disturbance, and scores of 70 or higher may reflect severe sleep disturbance.

Baseline, 12 weeks
Change in the Short Form Health Survey (SF-12), Baseline to Post-intervention
Tidsramme: Baseline, 8 weeks
The Short Form Health Survey (SF-12) is a 12-item self-report questionnaire that assesses aspects of physical health and mental well-being. Scoring is complex and includes both positive and negatively worded items and is translated into a score of 0-100. Higher scores indicate better physical and mental health functioning.
Baseline, 8 weeks
Proportion of Participants Who Completed the Study
Tidsramme: 12 weeks
Retention will be compared between the active intervention arms and is defined as the number of individuals randomized who did not withdraw from the study or were administratively censored.
12 weeks
Proportion of Participants Who Complete the Intervention
Tidsramme: 8 weeks
Completers are defined as randomized participants who either attend a minimum of 5 classes (MTIA arm) or view material for a minimum of 5 weeks in the MAPP. The proportion of completers will be compared between groups.
8 weeks
Client Satisfaction Questionnaire-internet at the End of the Intervention
Tidsramme: 8 weeks
The Client satisfaction questionnaire-internet (CSQ-I) is an 8-item measure developed in Germany to assess satisfaction with telehealth interventions. the CSQ-I consists of seven statements that address satisfaction with an online program and willingness to refer others. The investigators have adjusted the 4 response categories for an American sample to use the standard agreement scale (1=strongly disagree, 2= mildly disagree, 3=mildly agree, 4= strongly agree). Mean scores are calculated which can range from 1-4 with higher scores representing greater satisfaction. The questionnaire will be assessed among participants in the intervention arms at the end of the interventions.
8 weeks

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Susan Gaylord, PhD, University of North Carolina, Chapel Hill
  • Ledende efterforsker: Keri J Heilman, PhD, University of North Carolina, Chapel Hill
  • Ledende efterforsker: Maria Davila, PhD, Research Triangle Institute (RTI)

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

13. maj 2024

Primær færdiggørelse (Faktiske)

27. maj 2025

Studieafslutning (Faktiske)

27. maj 2025

Datoer for studieregistrering

Først indsendt

1. februar 2024

Først indsendt, der opfyldte QC-kriterier

1. februar 2024

Først opslået (Faktiske)

5. februar 2024

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

14. maj 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

13. maj 2026

Sidst verificeret

1. september 2025

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

Afidentificerede individuelle data, der understøtter resultaterne, vil blive delt fra 9 til 36 måneder efter offentliggørelsen, forudsat at den efterforsker, der foreslår at bruge dataene, har godkendelse fra et Institutional Review Board (IRB), Independent Ethics Committee (IEC) eller Research Ethics Board (REB) ), alt efter hvad der er relevant, og udfører en aftale om databrug/deling med UNC/RTI.

IPD-delingstidsramme

begynder 9 og fortsætter i 36 måneder efter offentliggørelsen

IPD-delingsadgangskriterier

For data, der tilhører UNC (Mindfulness program brug, deltagertilfredshed), skal brugere have godkendt IRB, IEC eller REB og en eksekveret aftale om databrug/deling med UNC.

For data, der tilhører RTI (demografi, hjertedata, psykologiske/adfærdsmæssige spørgeskemaer indsamlet ved hjælp af SMILE-appen), skal brugerne udføre en databrugs-/delingsaftale med RTI.

IPD-deling Understøttende informationstype

  • STUDY_PROTOCOL
  • SAP
  • ICF

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner